Skip to main content
. 2022 Jan 31;19(3):1654. doi: 10.3390/ijerph19031654

Table 1.

Sociodemographic data, mental health status, and knowledge of and attitude toward COVID-19 among participants according to vaccination status.

Variable Total
(n = 560)
Vaccinated Group
(n = 391)
Unvaccinated Group (n = 169) p-Value Effect Size
Age 21.4 ± 3.1 21.6 ± 3.4 21.0 ± 2.32 0.029 a 0.090
Gender 0.427 b 0.034
Male 218 (38.9%) 148 (37.9%) 70 (41.4%)
Female 342 (61.1%) 243 (62.1%) 99 (58.6%)
Household structure 0.621 b 0.041
Living alone 264 (47.1%) 185 (47.3%) 79 (46.8%)
With others 296 (52.9%) 206 (52.7%) 90 (53.2%)
Part-time job 0.753 b 0.013
Employed 406 (72.5%) 285 (72.9%) 121 (71.6%)
None 154 (27.5%) 106 (27.1%) 48 (28.4%)
Movement restrictions 0.504 b 0.049
Strict 56 (10.0%) 39 (10.0%) 17 (10.1%)
Except for shopping or work 444 (79.3%) 314 (80.3%) 130 (76.9%)
No 60 (10.7%) 38 (9.7%) 22 (13.0%)
Fear of COVID-19 infection (Yes) 464 (82.9%) 325 (83.1%) 139 (82.3%) 0.802 b 0.011
Knowledge about the COVID-19
vaccine (Yes)
Can one be reinfected after
recovering from
COVID-19 infection?
535 (95.5%) 375 (95.9%) 160 (94.7%) 0.517 b 0.027
Is there currently an
effective vaccine against
COVID-19?
413 (73.8%) 300 (76.7%) 113 (66.9%) 0.015 b 0.103
Importance of vaccination
(Likert scale: 1–5)
To protect self 5.0 [4.0–5.0] 5.0 [4.0–5.0] 4.0 [3.0–5.0] <0.001 a 0.326
To protect others 5.0 [4.0–5.0] 5.0 [4.0–5.0] 4.0 [4.0–5.0] <0.001 a 0.224
Anxiety symptoms (GAD-2 score ≥ 3) 85 (15.2%) 56 (14.3%) 29 (17.2%) 0.390 b 0.036
Depressive symptoms (PHQ-2 score ≥ 3) 72 (12.9%) 54 (13.8%) 18 (10.7%) 0.305 b 0.043

Note. Statistically significant results are in bold. GAD-2, generalized anxiety disorder. PHQ-2, Patient Health Questionnaire. GAD-2 and PHQ-2 scores of ≥3 are considered a positive screening. Data are expressed as means ± SD, n (%), or medians (interquartile range). a Results of the Mann–Whitney U test. b Results of the chi-squared test.